New EU legal case against AstraZeneca over vaccine supplies gets underway



© Reuters. FILE PHOTO: Vials of Oxford/AstraZeneca’s COVID-19 vaccine are pictured at a vaccination centre in Bierset, Belgium March 17, 2021. REUTERS/Yves Herman

BRUSSELS (Reuters) – A second legal case brought by the European Commission against AstraZeneca (NASDAQ:) over its delayed delivery of COVID-19 vaccines got underway in a Brussels court on Tuesday.

Officials familiar with the case said the lawsuit is mostly procedural – pertaining to the merits of the issue – after a first case was launched in April, and would allow the European Union to seek possible financial penalties.

The first legal action was about requesting faster deliveries, whereas the new one will concern the merit of the case.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

READ  AT&T's Mexico unit loses class action lawsuit to consumer watchdog





READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here